Structure-based design of selective fat mass and obesity associated protein (FTO) Inhibitors
Structure-based design of selective fat mass and obesity associated protein (FTO) Inhibitors
FTO catalyzes the Fe(II) and 2-oxoglutarate (2OG)-dependent modification of nucleic acids, including the demethylation of N6-methyladenosine (m6A) in mRNA. FTO is a proposed target for anti-cancer therapy. Using information from crystal structures of FTO in complex with 2OG and substrate mimics, we designed and synthesized two series of FTO inhibitors, which were characterized by turnover and binding assays, and by X-ray crystallography with FTO and the related bacterial enzyme AlkB. A potent inhibitor employing binding interactions spanning the FTO 2OG and substrate binding sites was identified. Selectivity over other clinically targeted 2OG oxygenases was demonstrated, including with respect to the hypoxia-inducible factor prolyl and asparaginyl hydroxylases (PHD2 and FIH) and selected JmjC histone demethylases (KDMs). The results illustrate how structure-based design can enable the identification of potent and selective 2OG oxygenase inhibitors and will be useful for the development of FTO inhibitors for use in vivo.
16609–16625
Shishodia, Shifali
1df779fa-3bc4-47df-976e-e0709634975d
Demetriades, Marina
27210f45-0fe9-4f7c-84c6-40de3738fffb
Zhang, Dong
19fc3359-5989-4043-a72b-ae83ba6afb00
Tam, Nok Yin
6b93953d-b06b-48c6-91a5-0345b21948d0
Maheswaran, Pratheesh
dfc4e01a-0ff0-40d9-8498-5ec90901ab4e
Clunie-O’Connor, Caitlin
89b8d4b7-7d64-4d93-aef2-c22da1f0f116
Tumber, Anthony
5cb525bc-4117-4138-b50e-21e9e4f25971
Leung, Ivanhoe K.H.
0f4fc3a1-9255-4c7e-aae6-26f74ab2af18
Ng, Yi Min
131cf8b3-42b9-42b0-a3e8-ac3a1833949f
Leissing, Thomas M.
a74c0782-c7e2-4cda-8830-a560a7de175b
El-Sagheer, Afaf
05b8295a-64ad-4fdf-ad57-c34934a46c04
Salah, Eidarus
d50abef8-c6ca-4db3-a029-e2e225518dd0
Brown, Tom
a64aae36-bb30-42df-88a2-11be394e8c89
Aik, Wei Shen
c640939c-2c7c-4f88-a7b6-d1d5e8ca16f5
McDonough, Michael A
b5bb2e07-1173-43a3-9079-111b45aac33c
Schofield, Christopher J.
e6290859-8eda-4bdc-9dfd-d4d682135027
25 November 2021
Shishodia, Shifali
1df779fa-3bc4-47df-976e-e0709634975d
Demetriades, Marina
27210f45-0fe9-4f7c-84c6-40de3738fffb
Zhang, Dong
19fc3359-5989-4043-a72b-ae83ba6afb00
Tam, Nok Yin
6b93953d-b06b-48c6-91a5-0345b21948d0
Maheswaran, Pratheesh
dfc4e01a-0ff0-40d9-8498-5ec90901ab4e
Clunie-O’Connor, Caitlin
89b8d4b7-7d64-4d93-aef2-c22da1f0f116
Tumber, Anthony
5cb525bc-4117-4138-b50e-21e9e4f25971
Leung, Ivanhoe K.H.
0f4fc3a1-9255-4c7e-aae6-26f74ab2af18
Ng, Yi Min
131cf8b3-42b9-42b0-a3e8-ac3a1833949f
Leissing, Thomas M.
a74c0782-c7e2-4cda-8830-a560a7de175b
El-Sagheer, Afaf
05b8295a-64ad-4fdf-ad57-c34934a46c04
Salah, Eidarus
d50abef8-c6ca-4db3-a029-e2e225518dd0
Brown, Tom
a64aae36-bb30-42df-88a2-11be394e8c89
Aik, Wei Shen
c640939c-2c7c-4f88-a7b6-d1d5e8ca16f5
McDonough, Michael A
b5bb2e07-1173-43a3-9079-111b45aac33c
Schofield, Christopher J.
e6290859-8eda-4bdc-9dfd-d4d682135027
Shishodia, Shifali, Demetriades, Marina, Zhang, Dong, Tam, Nok Yin, Maheswaran, Pratheesh, Clunie-O’Connor, Caitlin, Tumber, Anthony, Leung, Ivanhoe K.H., Ng, Yi Min, Leissing, Thomas M., El-Sagheer, Afaf, Salah, Eidarus, Brown, Tom, Aik, Wei Shen, McDonough, Michael A and Schofield, Christopher J.
(2021)
Structure-based design of selective fat mass and obesity associated protein (FTO) Inhibitors.
Journal of Medicinal Chemistry, 64 (22), .
(doi:10.1021/acs.jmedchem.1c01204).
Abstract
FTO catalyzes the Fe(II) and 2-oxoglutarate (2OG)-dependent modification of nucleic acids, including the demethylation of N6-methyladenosine (m6A) in mRNA. FTO is a proposed target for anti-cancer therapy. Using information from crystal structures of FTO in complex with 2OG and substrate mimics, we designed and synthesized two series of FTO inhibitors, which were characterized by turnover and binding assays, and by X-ray crystallography with FTO and the related bacterial enzyme AlkB. A potent inhibitor employing binding interactions spanning the FTO 2OG and substrate binding sites was identified. Selectivity over other clinically targeted 2OG oxygenases was demonstrated, including with respect to the hypoxia-inducible factor prolyl and asparaginyl hydroxylases (PHD2 and FIH) and selected JmjC histone demethylases (KDMs). The results illustrate how structure-based design can enable the identification of potent and selective 2OG oxygenase inhibitors and will be useful for the development of FTO inhibitors for use in vivo.
Text
acs.jmedchem.1c01204
- Version of Record
More information
Accepted/In Press date: 11 November 2021
e-pub ahead of print date: 11 November 2021
Published date: 25 November 2021
Identifiers
Local EPrints ID: 477942
URI: http://eprints.soton.ac.uk/id/eprint/477942
ISSN: 0022-2623
PURE UUID: 956528ee-829b-47ff-9403-46a4d93f0233
Catalogue record
Date deposited: 16 Jun 2023 16:48
Last modified: 28 Aug 2024 01:40
Export record
Altmetrics
Contributors
Author:
Shifali Shishodia
Author:
Marina Demetriades
Author:
Dong Zhang
Author:
Nok Yin Tam
Author:
Pratheesh Maheswaran
Author:
Caitlin Clunie-O’Connor
Author:
Anthony Tumber
Author:
Ivanhoe K.H. Leung
Author:
Yi Min Ng
Author:
Thomas M. Leissing
Author:
Afaf El-Sagheer
Author:
Eidarus Salah
Author:
Wei Shen Aik
Author:
Michael A McDonough
Author:
Christopher J. Schofield
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics